CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia

scientific article

CD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1034/J.1600-6143.2003.00150.X
P698PubMed publication ID12780568
P5875ResearchGate publication ID10730117

P50authorErika Jensen-JarolimQ18574776
Georg A. RothQ38640006
Bernhard MoserQ42428017
Markus BrunnerQ56452167
Christoph BuchtaQ56943388
Hendrik J AnkersmitQ61796027
George Boltz-NițulescuQ112309012
P2093author name stringAndreas Zuckermann
Edith Bielek
Ivo Volf
Ernst Wolner
Christiane Rosin
Werner Schmid
P2860cites workA quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG).Q33334757
Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.Q33404511
Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibodyQ37609861
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donorsQ44208456
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.Q52962713
Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII)Q58045039
Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT)Q69774344
Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulinsQ70122034
A controlled randomized double-blind study of antilymphoblast globulin in cadaver renal transplantationQ70243652
A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulinQ72672810
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibodyQ73502584
Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulinesQ73832050
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosisQ77768132
Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipientsQ78024348
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectthymocyteQ7799635
thrombocytopeniaQ585285
platelet aggregationQ14913634
P304page(s)754-759
P577publication date2003-06-01
P1433published inAmerican Journal of TransplantationQ4744273
P1476titleCD32-mediated platelet aggregation in vitro by anti-thymocyte globulin: implication of therapy-induced in vivo thrombocytopenia
P478volume3

Reverse relations

cites work (P2860)
Q33401507Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections?
Q53313488Diversification of IgG effector functions.
Q33422771Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG).
Q34616147Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
Q46245186Modification of immunological features in human platelets during sepsis.
Q38445344Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance
Q46759424Oxidation by hypochlorite converts protective HDL into a potent platelet agonist
Q39088502The Role and Function of Fcγ Receptors on Myeloid Cells
Q54239049Thrombocytopenia after liver transplantation: Should we care?

Search more.